Fuzeon (enfuvirtide) is a protein pharmaceutical. Enfuvirtide was first approved as Fuzeon on 2003-03-13. It is used to treat acquired immunodeficiency syndrome and HIV infections in the USA. It has been approved in Europe to treat HIV infections.
|Indication||acquired immunodeficiency syndrome, hiv infections|
|Drug Class||Peptides: antiviral peptides; antivirals|